Ribonucleic Acid News and Research

RSS

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Researchers assessed the protective efficacy of the temperature-stable orally delivered vaccines against respiratory viral pathogens.

14 Apr 2022

Exploring strategies for successful delivery of messenger RNA therapeutics

Researchers reviewed the material properties and administration routes that could successfully deliver a messenger ribonucleic acid therapeutic agent to its targeted site.

14 Apr 2022

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Researchers reviewed non-viral nano-vectors used for delivering the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated genome editing system.

14 Apr 2022

Study reveals natural infection of pangolins with human RSV

A new study aimed to determine whether humans were able to transmit RSV to Malayan pangolins.

13 Apr 2022

Quantum computing to predict RNA secondary structures

Researchers investigate the possibility of using quantum computing to create methods that can more effectively and rapidly solve these structures.

13 Apr 2022

Structural differences between SARS-CoV-1 and SARS-CoV-2 RBDs

A new study compares the SARS-CoV-2 RBD to the SARS-CoV RBD using computational methods to understand their binding affinities to ACE2.

13 Apr 2022

Case of probable transmission of tick-borne encephalitis virus from an unvaccinated mother to an infant through breast-feeding

A recent study discusses a case report of the probable vertical transmission of tick-borne encephalitis virus (TBEV) from an unvaccinated mother to her newborn via breast milk.

13 Apr 2022

Study explores myopericarditis incidence and COVID-19 vaccination

Researchers investigated the impact of COVID-19 vaccination on the incidence of myopericarditis.

13 Apr 2022

Impact of COVID-19 infection and vaccination on antibody response

A new study assessed the impact of COVID-19 and vaccination on antibody responses.

13 Apr 2022

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

Researchers examined the risk of breakthrough COVID-19 infections, hospitalizations, and mortality among COVID-19-vaccinated cancer patients.

13 Apr 2022

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

A recent study assessed the efficacy of the second and third doses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccines against the SARS-CoV-2 Omicron and Delta variants in outpatient settings.

13 Apr 2022

Treg cell Notch receptors drive SARS-CoV-2-induced MIS-C

In a recent study under consideration at Nature Portfolio Journal and posted to the Research Square* preprint server, researchers demonstrated the evolution of multi-system inflammatory syndrome in children (MIS-C) following acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

12 Apr 2022

mRNA vaccines induce CD8+ T cells that may reduce COVID-19 severity

In a recent study under consideration at Nature Portfolio Journal and posted to the Research Square* preprint server, researchers characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S)-specific cluster of differentiation 8 (CD8+) T cell responses.

12 Apr 2022

Development of 18 monoclonal antibodies against 9 SARS-CoV-2 proteins

A new study aimed to generate, characterize, and optimize Abs against SARS-CoV-2 proteins.

12 Apr 2022

Dysregulated retroelements associated with autoimmunity in COVID-19

Researchers investigate potential interactions between retro-elements shared between the human and coronavirus genomes.

12 Apr 2022

Does COVID-19 vaccination affect IVF treatments?

A new study assesses the impact of COVID-19 vaccination in women undergoing assisted reproduction.

12 Apr 2022

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

In a new study, researchers quantified the serological responses following the third dose of mRNA-based COVID-19 vaccines in patients with hematological malignancies.

12 Apr 2022

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

A recent study published in PLoS ONE assessed the association of the prevalence of the COVID-19 pandemic with vaccine efficacy.

12 Apr 2022

Novel Hendra virus variant detected in flying fox urine

Researchers reported on the detection of a novel Hendra virus variant of genotype 2 (HeV-g2) in the urine of grey-headed and black flying foxes in Australia.

12 Apr 2022

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

Researchers evaluated the immunogenicity of Pfizer’s BNT162b2 and Moderna’s mRNA-1273 vaccines offered as the fourth dose against SARS-CoV-2.

12 Apr 2022

Ribonucleic Acid News and Research

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Exploring strategies for successful delivery of messenger RNA therapeutics

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Study reveals natural infection of pangolins with human RSV

Quantum computing to predict RNA secondary structures

Structural differences between SARS-CoV-1 and SARS-CoV-2 RBDs

Case of probable transmission of tick-borne encephalitis virus from an unvaccinated mother to an infant through breast-feeding

Study explores myopericarditis incidence and COVID-19 vaccination

Impact of COVID-19 infection and vaccination on antibody response

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

Treg cell Notch receptors drive SARS-CoV-2-induced MIS-C

mRNA vaccines induce CD8+ T cells that may reduce COVID-19 severity

Development of 18 monoclonal antibodies against 9 SARS-CoV-2 proteins

Dysregulated retroelements associated with autoimmunity in COVID-19

Does COVID-19 vaccination affect IVF treatments?

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

Novel Hendra virus variant detected in flying fox urine

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News